Genetic and phenotypic features familial intrahepatic cholestasis: case report
Open Access
- 16 July 2026
- journal article
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 1,p. 143-152
Abstract
Familial intrahepatic cholestasis is a heterogeneous group of genetic disorders affecting the secretion and transport of bile acids. Progressive familial intrahepatic cholestasis (PFIC) may debut at different periods of childhood and in adults. Currently, 13 types are known, associated with changes in various genes and extreme phenotypic variability. PFIC2 type is associated with changes in the ABCB11 gene, causing deficiency or dysfunction of the ATP-binding transport protein that excretes bile acids from the hepatocyte into the bile canaliculi against the concentration gradient. Accumulation of bile acids in hepatocytes leads to the development of cholestasis, ranging from transient to fatal progressive familial intrahepatic cholestasis, accompanied by jaundice, growth retardation, liver cirrhosis, liver failure. Timely diagnosis is extremely important for the initiation of therapy to prevent cholestatic liver damage. The presented clinical case demonstrates the possibility of nosological diagnosis of a rare hereditary pathology and the effectiveness of the therapy at this stage. The conducted genetic study allowed us to diagnose familial intrahepatic cholestasis. The clinical phenotype in this patient does not fully correspond to benign recurrent intrahepatic cholestasis type 2 (OMIM # 605479) and PFIC2 (OMIM # 601847), an intermediate phenotype is likely to occur. Dynamic observation and control of clinical, laboratory and imaging characteristics are necessary in order to timely detect disease progression.Keywords
This publication has 31 references indexed in Scilit:
- The spectrum of novel ABCB11 gene variations in children with progressive familial intrahepatic cholestasis type 2 in Pakistani cohortsScientific Reports, 2024
- Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutationsGenetics in Medicine, 2024
- EASL Clinical Practice Guidelines on genetic cholestatic liver diseasesJournal of Hepatology, 2024
- Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiencyJHEP Reports, 2023
- Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohortGastroenterología y Hepatología, 2022
- The spectrum of Progressive Familial Intrahepatic Cholestasis diseases: Update on pathophysiology and emerging treatmentsEuropean Journal of Medical Genetics, 2021
- ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and OutcomesThe Journal of Pediatrics, 2021
- Genotype correlates with the natural history of severe bile salt export pump deficiencyJournal of Hepatology, 2020
- Drug-Induced Liver Injury — Types and PhenotypesNew England Journal of Medicine, 2019
- Familial intrahepatic cholestasis: New and wide perspectivesDigestive and Liver Disease, 2019